Health Canada’s approval of a new 240mg strength tablet will provide patients and their care providers with additional dosing options to address a variety of treatment needs TORONTO, ON —… Read More
VICTORIA, BC — StarFish Medical announces its latest webinar Venture Capital in Medtech, where three seasoned venture capital experts share their insights, stories and lessons learned in a 90-minute live… Read More
The University of Washington and the University of California, Los Angeles have been approved to study PEX010 in clinical trials for mental health conditions VANCOUVER, BC — Filament Health Corp…. Read More
Recruitment of individuals with spinal cord injury (SCI) initiated at Shirley Ryan AbilityLab in Chicago Chronic SCI cohort results expected in mid-2024 and subacute SCI cohort results in late 2024/early… Read More
VANCOUVER, BC — (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to… Read More
